Clinical Trials
8 trialsNCT04861181 2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4 Terminated
NCT03164980 2025-03-20
COMPASS
North Eastern German Society of Gynaecological Oncology
Phase 4 Terminated
NCT03051516 2024-02-28
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Fred Hutchinson Cancer Center
Phase 4 Terminated
NCT03858166 2024-01-05
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
Shandong University
Phase 4 Terminated
NCT03423082 2020-10-28
Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
University of Pittsburgh
Phase 4 Terminated
NCT00730847 2019-11-05
A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.
GlaxoSmithKline
Phase 4 Terminated
NCT02035345 2016-12-08
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Massachusetts General Hospital
Phase 4 Terminated
NCT00629993 2011-03-01
Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities
Columbia University
Phase 4 Terminated